miglustat,
N-(n-butyl)deoxy-nojirimycin,
N-(n-butyl)deoxynojirimycin,
n-butyl deoxynojirimycin,
n-butyldeoxynojirimycin,
OGT 918,
SC 48334,
SC-48334,
Zavesca,
Miglustat,
Zavesca,
N-Butyldeoxynojirimycin,
72599-27-0,
NB-DNJ,
N-Butylmoranoline,
N-butyl-1-deoxynojirimycin,
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol,
BuDNJ,
n-Butyl deoxynojirimycin,
Butyldeoxynojirimycin,
n-Butyl dnj,
N-(n-Butyl)deoxynojirimycin,
SC-48334,
OGT 918,
N-Butyl-DNJ,
SC 48334,
UNII-ADN3S497AZ,
OGT-918,
3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R,3r,4R,5S)-,
ADN3S497AZ,
CHEMBL1029,
CHEBI:50381,
D-Glucitol, 1,5-(butylimino)-1,5-dideoxy-,
MFCD00272581,
SC48334,
DSSTox_CID_25618,
DSSTox_RID_81006,
DSSTox_GSID_45618,
Miglustat [USAN],
miglustatum,
Vevesca,
3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-,
Zavesca (TN),
CAS-72599-27-0,
N-Bu-DNJ,
Miglustat, Hydrochloride,
N-Butyl-deoxynojirimycin,
NBV,
Brazaves,
Miglustat [USAN:INN:BAN],
NCGC00018140-02,
Brazaves (TN),
1,5-Dideoxy-1,5-N-butylimino-D-glucitol,
AC1L1BHJ,
N-(n-butyl)-1,5-dideoxy-1,5-imino-D-glucitol,
Miglustat (JAN/USAN/INN),
SCHEMBL246893,
BICL4040,
GTPL4841,
DTXSID6045618,
BDBM18355,
UQRORFVVSGFNRO-UTINFBMNSA-N,
HMS2090N20,
ZINC3794711,
Tox21_110830,
3917AH,
AN-010,
AKOS028109118,
Tox21_110830_1,
ACN-025888,
API0003392,
CS-2776,
DB00419,
SB18741,
NCGC00024452-03,
NCGC00024452-04,
BC677641,
HY-17020,
LS-116261,
N-(n-Butyl)-1-deoxynojirimycin min. 99%,
N-Butyldeoxynojirimycin, film (dried in situ),
D05032,
AB00489939-10,
SR-01000000043,
SR-01000000043-2,
W-203639,
Miglustat (USAN/INN),
D0HR8Z,
N-(n-butyl)deoxy-nojirimycin,
C10H21NO4,
CID51634,
C10-H21-N-O4,
CS-P-01695,
1,5-(Butylimino)-1,5-dideoxy, D-glucitol,
A12797,
C059896,
(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)-3,4,5-piperidinetriol,